Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C)

The human histone demethylases of the KDM4 (JMJD2) family have been associated to diseases such as prostate and breast Cancer, as well as X-linked mental retardation. Therefore, these Enzymes are considered oncogenes and their selective inhibition might be a possible therapeutic approach to treat Cancer. Here we describe a heterocyclic ring system library screened against the Histone Demethylase KDM4C (JMJD2C) in the search for novel inhibitory scaffolds. A 4-hydroxypyrazole scaffold was identified as an inhibitor of KDM4C; this scaffold could be employed in the further development of novel therapeutics, as well as for the elucidation of the biological roles of KDM4C on epigenetic regulation.